financetom
Business
financetom
/
Business
/
Carlyle's Q2 profit misses estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Carlyle's Q2 profit misses estimates
Aug 5, 2024 3:35 AM

NEW YORK (Reuters) - Private equity firm Carlyle Group ( CG ) reported a larger-than expected 11.7% year-on-year drop in second-quarter distributable earnings on Monday, as record revenue from management and transaction fees did not offset a big drop in performance fees.

The decline was due to Carlyle generating less cash from asset sales. This resulted in smaller profit, because Carlyle gets a cut of the cash generated as performance fees. Fees it receives for managing investors' money jumped, but were not enough to make up the difference.

Distributable earnings, which measures cash that can be returned to shareholders, dropped to $343 million from $389 million a year earlier. This translated into after-tax distributable earnings of 78 cents per share, which fell short of the average Wall Street analyst estimate of 83 cents, according to LSEG data.

The Washington, D.C.-based firm reported fee-related earnings of $273 million, its highest ever and a 32% increase from the previous year. Its fee-related earnings margin came in at 46%, up from 34% in the same quarter last year.

Carlyle's assets under management rose 13% from the prior quarter to $435 billion.

Carlyle's corporate private equity funds rose 2% during the quarter, real estate funds appreciated 1%, infrastructure and natural resources funds gained 3%, and global credit funds appreciated 3%. Last month, bigger rival Blackstone reported that its core private equity funds appreciated by 2%, and opportunistic real estate funds grew by 0.3%.

Carlyle raised $12.4 billion from investors during the quarter, primarily driven by commitments in real estate and the closing of four new collateralized loan obligations.

The alternative asset manager raised $2.8 billion for its fifth Japan buyout fund in the quarter, marking the largest Japan-focused buyout fund ever.

Carlyle spent $4 billion on new acquisitions and retained $83 billion of unspent capital. Together with private equity firm KKR, it won an auction for a $10 billion student loan book from Discover Financial Services ( DFS ) in June.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Loar Likely to Benefit From Strong A&D Fundamentals in Q3, RBC Says
Loar Likely to Benefit From Strong A&D Fundamentals in Q3, RBC Says
Nov 12, 2024
12:41 PM EST, 11/12/2024 (MT Newswires) -- Loar Holdings ( LOAR ) is expected to gain in Q3 from strong Aerospace & Defense fundamentals, scarcity value, and a positive M&A landscape, RBC Capital Markets said in a report emailed Tuesday. Loar ( LOAR ) will report its Q3 earnings on Wednesday, RBC said. We expect the company to exceed 3Q24...
Packaging Corp Of America Insider Sold Shares Worth $3,007,738, According to a Recent SEC Filing
Packaging Corp Of America Insider Sold Shares Worth $3,007,738, According to a Recent SEC Filing
Nov 12, 2024
12:43 PM EST, 11/12/2024 (MT Newswires) -- Robert P. Mundy, Executive Vice President & CFO, on November 08, 2024, sold 12,500 shares in Packaging Corp Of America ( PKG ) for $3,007,738. Following the Form 4 filing with the SEC, Mundy has control over a total of 43,954 shares of the company, with 43,954 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/75677/000095017024124978/xslF345X05/ownership.xml...
Apogee Therapeutics' Q3 Net Loss Widens
Apogee Therapeutics' Q3 Net Loss Widens
Nov 12, 2024
08:45 AM EST, 11/12/2024 (MT Newswires) -- Apogee Therapeutics ( APGE ) reported a Q3 net loss Tuesday of $49 million, wider than the loss of $20.8 million a year earlier. Analysts polled by Capital IQ expected a loss of $43.9 million. No revenue for the quarter ended Sept. 30 was reported. As of Sept. 30, the company said it...
Novavax Q3 Loss Narrows, Revenue Falls; 2024 Revenue Guidance Lowered -- Shares Down Pre-Bell
Novavax Q3 Loss Narrows, Revenue Falls; 2024 Revenue Guidance Lowered -- Shares Down Pre-Bell
Nov 12, 2024
08:45 AM EST, 11/12/2024 (MT Newswires) -- Novavax ( NVAX ) reported a Q3 loss Tuesday of $0.76 per diluted share, narrower than the loss of $1.26 a year earlier. Four analysts polled by Capital IQ expected a loss of $0.81. Revenue for the quarter ended Sept. 30 was $84.5 million, down from $187 million a year earlier. Five analysts...
Copyright 2023-2026 - www.financetom.com All Rights Reserved